More deaths in the new study group for this product. More overall adverse reactions for the new product. Here's the top-line comparison: Healthcare encounter

More deaths in the new study group for this product. More overall adverse reactions for the new product. Here's the top-line comparison: Healthcare encounter: new: 80 (0.4) existing: 120 (0.6) Each group had roughly 20k participants, mostly white. No actual control group, no independent third party study. Junk.